Macrogenics Inc
NASDAQ: MGNXIncorporated in Delaware · 6 known investors
Find your way into Macrogenics Inc
MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
Founders & leadership
Investors · 6
Valuation · disclosed
Disclosed events$919.4Mvaluation at IPOFeb 2014 · $36.50/share · 424B4
filing ↗Source: SEC prospectus filings, and round valuations the company or its investors disclosed — follow each entry's link for the claim.
Founder mafia
2 people who came through Macrogenics Inc went on to found or lead other companies.
Competitors · 2
by search overlap
Biogen Idec97 shared keywordsBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
Thumbnail for Seragon Pharmaceuticals85 shared keywordsGenentech is a biotechnology company that develops and manufactures breakthrough medicines in the United States, backed by a $50 billion commitment to U.S. manufacturing and scientific innovation.
Companies competing with Macrogenics Inc for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Macrogenics Inc do?
- MacroGenics is a clinical-stage biopharmaceutical company developing antibody-based therapies for cancer patients. It advances a pipeline of product candidates using proprietary platforms for antibody-drug conjugates, bispecific checkpoint antibodies, and T-cell engagers.
- Who are Macrogenics Inc's investors?
- Macrogenics Inc's investors include Havencrest Capital Management, Ridgeback Capital, RiverVest Venture Partners, Sanofi Ventures, La Caisse, TPG.